000 01588 a2200457 4500
005 20250515233240.0
264 0 _c20101202
008 201012s 0 0 eng d
022 _a1537-162X
024 7 _a10.1097/WNF.0b013e3181de8966
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLotrich, Francis E
245 0 0 _aLabile anger during interferon alfa treatment is associated with a polymorphism in tumor necrosis factor alpha.
_h[electronic resource]
260 _bClinical neuropharmacology
_cJul 2010
300 _a191-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnger
650 0 4 _aAntiviral Agents
_xadverse effects
650 0 4 _aFatigue
_xgenetics
650 0 4 _aFemale
650 0 4 _aHepatitis C
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInterferon alpha-2
650 0 4 _aInterferon-alpha
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPolymorphism, Single Nucleotide
650 0 4 _aPsychiatric Status Rating Scales
650 0 4 _aRecombinant Proteins
650 0 4 _aSerotonin Plasma Membrane Transport Proteins
_xgenetics
650 0 4 _aTumor Necrosis Factor-alpha
_xblood
650 0 4 _aYoung Adult
700 1 _aFerrell, Robert E
700 1 _aRabinovitz, Mordechai
700 1 _aPollock, Bruce G
773 0 _tClinical neuropharmacology
_gvol. 33
_gno. 4
_gp. 191-7
856 4 0 _uhttps://doi.org/10.1097/WNF.0b013e3181de8966
_zAvailable from publisher's website
999 _c20001147
_d20001147